Quantitative 201thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis-Reference-Cited by-同舟云学术

Quantitative 201thallium scintigraphy for prediction of histological response to neoadjuvant chemotherapy in osteosarcoma; systematic review and meta-analysis

Published:2015-09 Issue:3 Volume:24 Page:194-199
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Kubo Tadahiko,Shimose Shoji,Fujimori Jun,Furuta Taisuke,Ochi Mitsuo

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference32 articles.

1. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol;Bacci;Eur. J. Cancer,2001

2. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols;Bielack;J. Clin. Oncol.,2002

3. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup;Lewis;J. Natl. Cancer Inst.,2007

4. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials;Eselgrim;Pediatr. Blood Cancer,2006

5. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol;Meyers;J. Clin. Oncol.,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 ( HMGA2 ) in Osteosarcoma;Orthopaedic Surgery;2022-04-07

2. Thallium Use, Toxicity, and Detoxification Therapy: An Overview;Applied Sciences;2021-09-08

3. 99mTc-MIBI Scintigraphy for the Preoperative Assessment of Histological Response to Neoadjuvant Chemotherapy in Patients With Osteosarcoma: A Systematic Review and a Bivariate Meta-Analysis;Frontiers in Oncology;2020-05-22

4. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis;Journal of Orthopaedic Surgery and Research;2020-02-13

5. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy;Medicine;2018-12